alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Clinical trials

Clinical trials

Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.

If you are thinking about joining a trial

A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.

Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.

Clear filters Download all 7,816 as CSV

"Open to new participants" means the registry status is RECRUITING or NOT_YET_RECRUITING — 1,523 of the 7,816 records. That is what the sponsor last told the registry, which can be months out of date.
Location is by country. This pull of the registry records the countries a study runs in, not its individual sites, so we cannot filter by US state or city — and we are not going to guess one. To find the nearest site, open a trial's record below: the official page lists every location with its contact details.

Showing 6,351–6,375 of 7,816 matching trials · page 255 of 313, 25 per page.

Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.

Registered Alzheimer's clinical trials. Every ID links to its official ClinicalTrials.gov record.
Trial Phase Status Enrolled Sponsor Last updated
Influence of Beta Amyloid Imaging on Care of Patients Cognitive Complaints.
NCT02309723
Beta amyloid imaging
Runs in: United States · 1 site 		NA
other		 COMPLETED 315 Tufts Medical Center
OTHER		 2017-04-10
The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients
NCT00255086
Memantine; Placebo pill
Runs in: United States · 1 site 		PHASE3
symptomatic-cholinergic		 COMPLETED 17 Stanford University
OTHER		 2017-04-07
Mild Cognitive Impairment in Parkinson's Disease
NCT01519271
Exelon Patch (rivastigmine transdermal system); Placebo Patches
Runs in: United States · 1 site 		PHASE4
symptomatic-cholinergic		 COMPLETED 28 University of Pennsylvania
OTHER		 2017-04-07
Pilot Study: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Prevention
NCT01780974
Lipoic Acid plus Omega-3 Fatty Acids; Placebo
Runs in: United States · 2 sites 		PHASE1|PHASE2
other		 COMPLETED 42 Oregon Health and Science University
OTHER		 2017-04-07
Safety Study of Sargramostim in Treating Patients With Mild Cognitive Impairment Due to Alzheimer's Disease
NCT02667496
Sargramostim GZ402664; Placebo; Florbetapir F18
Runs in: United States · 1 site 		PHASE2
anti-inflammatory		 WITHDRAWN 0 Sanofi
INDUSTRY		 2017-04-07
Brain Aging Project--Kansas University
NCT00267124
Runs in: United States · 1 site 		NA
other		 COMPLETED 172 University of Kansas Medical Center
OTHER		 2017-04-06
Efficacy of Pain Treatment on Depression in Patients With Dementia
NCT02267057
Paracetamol; Buprenorphine; Paracetamol placebo; Buprenorphine placebo
Runs in: Norway · 1 site 		PHASE4
other		 COMPLETED 163 University of Bergen
OTHER		 2017-04-04
Mealtime Symptoms in Dementia
NCT02269956
12 week feasibility study 		NA
other		 COMPLETED 132 Duke University
OTHER		 2017-04-04
Evaluation of a Brief Surf the Urge Intervention
NCT02771886
Surf the Urge
Runs in: United States · 1 site 		NA
other		 COMPLETED 36 Kimberly N Schubert
OTHER		 2017-04-04
The Effects of Anesthesia on Patients Undergoing Surgery for Repair of a Thoracoabdominal Aneurysm.
NCT01772537
Propofol; isoflurane
Runs in: United States · 1 site 		NA
other		 TERMINATED 14 Johns Hopkins University
OTHER		 2017-03-31
Effects of a NeuroAD System, for the Treatment of Alzheimer Disease
NCT02166827
NeuroAD; Sham TMS+Cog
Runs in: Israel · 1 site 		NA
other		 TERMINATED 1 Neuronix Ltd
INDUSTRY		 2017-03-31
Deep Brain Stimulation for the Treatment of Alzheimer's Disease
NCT01559220
Deep Brain Stimulation
Runs in: United States · 1 site 		NA
other		 COMPLETED 3 Ali Rezai, MD
OTHER		 2017-03-30
Oral Health Intervention Pilot Study for Individuals With Memory Problems
NCT01808235
Oral Health Intervention
Runs in: United States · 1 site 		NA
other		 COMPLETED 12 Duke University
OTHER		 2017-03-30
ATP in Alzheimer Disease
NCT02279511
ADENOSINE TRIPHOSPHATE; PLACEBO
Runs in: Spain · 2 sites 		PHASE2
other		 COMPLETED 20 Sara Varea
OTHER		 2017-03-29
Neurogenetic Pharmaceuticals (NGP) 555 in Healthy Volunteers (14 Day Multiple Ascending Dose)
NCT02537938
NGP 555
Runs in: United States · 1 site 		PHASE1
other		 COMPLETED 24 NeuroGenetic Pharmaceuticals Inc
INDUSTRY		 2017-03-29
Rivastigmine Capsules in Patients With Probable Vascular Dementia
NCT00130338
Rivastigmine 		PHASE3
symptomatic-cholinergic		 COMPLETED 521 Novartis
INDUSTRY		 2017-03-28
Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.
NCT00731224
Rivastigmine transdermal patch
Runs in: Australia; Malaysia; South Korea; Thailand; Turkey (Türkiye) · 40 sites 		PHASE4
symptomatic-cholinergic		 COMPLETED 380 Novartis Pharmaceuticals
INDUSTRY		 2017-03-28
Energy Metabolism and Cognitive Aging
NCT00777010
Ketogenic diet; Healthy high carbohydrate diet
Runs in: United States · 1 site 		NA
other		 COMPLETED 62 University of Cincinnati
OTHER		 2017-03-24
Maraviroc Intensification and Peripheral Blood Monocyte HIV DNA Levels
NCT00987948
maraviroc (Selzentry)
Runs in: United States · 1 site 		PHASE2
other		 COMPLETED 15 University of Hawaii
OTHER		 2017-03-22
Study Evaluating TheSafety And Efficacy Of PF-05212377 Or Placebo In Subjects With Alzheimer's Disease With Existing Neuropsychiatric Symptoms On Donepezil
NCT01712074
PF-05212377 (SAM-760); Placebo
Runs in: Canada; Chile; France; Germany; Spain; United Kingdom; Un... · 60 sites 		PHASE2
symptomatic-cholinergic		 TERMINATED 186 Pfizer
INDUSTRY		 2017-03-20
18-months Safety Follow-up Study of AADvac1, an Active Tau Vaccine for Alzheimer's Disease
NCT02031198
AADvac1
Runs in: Austria · 4 sites 		PHASE1
other		 COMPLETED 25 Axon Neuroscience SE
INDUSTRY		 2017-03-17
The Efficacy of Butylphthalide Soft Capsules in Patents With VCIND
NCT02993367
Butylphthalide Soft Capsules; Placebo Butylphthalide Soft Capsules
Runs in: China · 1 site 		PHASE2|PHASE3
other		 UNKNOWN 200 The Second Hospital of Hebei Medical University
OTHER		 2017-03-16
Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)
NCT01799941
Nuedexta (DM 20 mg/Q 10 mg)
Runs in: United States · 1 site 		PHASE4
other		 COMPLETED 367 Avanir Pharmaceuticals
INDUSTRY		 2017-03-15
Pilot Study of Aerobic Exercise in Early Alzheimer's Disease(AD)
NCT01128361
Aerobic Exercise; Stretching
Runs in: United States · 1 site 		NA
other		 COMPLETED 76 Jeff Burns, MD
OTHER		 2017-03-13
Open Label Extension Study Evaluating Safety and Tolerability of AAB-003 (PF-05236812) in Subject With Mild to Moderate Alzheimer's Disease
NCT01369225
AAB-003 (PF-05236812); AAB-003 (PF-05236812); AAB-003 (PF-05236812)...
Runs in: South Korea; United States · 21 sites 		PHASE1
other		 COMPLETED 52 Pfizer
INDUSTRY		 2017-03-10

This table is wider than a phone screen — swipe it sideways to see the rest.

Where these trials come from

Registry
ClinicalTrials.gov, pulled through their public API (v2)
Trials in the file
7,816
Source file
trials.csv (3.8 MB, 7816 rows)
Basis
Measured These are registry records as submitted by each study's sponsor.

What could make this misleading

Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.

Always check the official record before acting on anything here. This is a summary, not medical advice.

Related evidence Treatments → What the drugs that finished their trials actually achieved.

From the research library

The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.

Clinical trials

All 162 studies on Clinical trials →